Dados do Resumo

Título

NAVIGATION PROGRAM IN HEMATOLOGICAL NEOPLASMS: AN EXPERIENCE REPORT FROM A PHILANTHROPIC HOSPITAL 

Introdução

In the oncology journey, the nurse navigator (NP) is responsible for coordinating care, ensuring referral to the multidisciplinary team, identifying biopsychosocial barriers, as well as educating and advocating for the patient. Many services currently have oncology navigation programs (NP), but there are still few NP aimed at hematological neoplasms. Hematology includes malignant and non-malignant conditions and the main hematological neoplasms are lymphomas, leukemias and multiple myeloma. Treatment is wide-ranging, including chemotherapy, immunotherapy, target therapy, radiotherapy, bone marrow transplantation and CAR-T. Considering the complexity of oncohematology, the EN plays an important role in ensuring a better patient experience.

Objetivo

To describe a navigation program for hematological neoplasms.

Métodos

Experience report of a navigation program in a philanthropic hospital in São Paulo.

Resultados

The NP was implemented in January 2022, has 3 specialist nurses, with more than 10 years' professional experience in oncohematology. The diagnoses are leukemias, lymphomas, myelomas, myelodysplasias and myelo-proliferative syndromes. Currently, all oncohematology patients treated at the oncology center have the support of a nurse navigator. The inclusion criteria for the NP are only oncohematological diagnoses and the exclusion criteria are benign hematological diagnoses and clinical trial patients, who already have the help of the researchers in coordinating their oncological journey. The navigators are divided by medical team, with 2 nurses caring for a hematologist with the largest number of patients and 1 nurse caring for the patients of 10 hematologists. Patients are navigated throughout the cancer continuum and patients are picked up mainly through medical consultations. During the oncological diagnosis, the EN is called in by the hematologist, at which point he identifies barriers to diagnostic conclusion, provides guidance and acts as a facilitator in scheduling and releasing tests. After confirming the oncological diagnosis, the EN establishes an individualized care plan, assesses biopsychosocial risks and carries out the patient and family education process. Medical returns are monitored by the EN, where risks and barriers are reassessed. During the journey, telephone monitoring is carried out periodically to look for early signs and symptoms.

Conclusões

Currently, the navigation program for oncohematological patients is consolidated in the service and reflects good results such as improved patient experience, clinical outcome and operational performance. The role of the ENO for hematological neoplasms is still poorly described in the literature, and it is necessary to invest in studies with a scope design and the necessary care for this patient profile.